Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

NeuroLF System
NeuroLF System
NeuroLF System
NeuroLF System
NeuroLF System
NeuroLF System
NeuroLF System
NeuroLF System
2025

Share:

NeuroLF System

Brain Positron Emission Tomography System

Dementia and Alzheimer’s disease is a worldwide problem for which proper diagnosis is critical to offer individualized treatment. Positron Emission Tomography (PET) is considered the gold standard to diagnose Alzheimer’s disease but today’s PET devices are large and expensive preventing its broad availability. Our dedicated brain PET system NeuroLF is small and offers an unmet price-value proposition to allow for wide adoption and application. Beside a significant initial addressable market, future NeuroLF applications will allow for attractive revenue growth and addresses a huge socio-economic problem at the same time.

Client / Manufacturer

Positrigo

Zürich, CH

Sanmina

Örnsköldsvik, SE
Design

Helbling Technik AG

Zürich, CHLennart Behrmann
Date of Launch
2024
Development Time
more than 24 Month
Target Regions
Asia, Europe, North America, South America
Target Groups
"Hospitals and Neurology Offices"

RELATED PROJECTS